Search - tctmd.com

Displaying 281 - 300 of 377

News Conference News TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

September 16, 2014

Presentation TCT 2014

Case #5: Resuscitated Out-of-Hospital Cardiac Arrest

Presenter: Emmanouil S. Brilakis, Jose P.S. Henriques, Stefan K. James, Keith G. Oldroyd, Thomas D. Stuckey, Colin M. Barker

September 15, 2014

Presentation TCT 2014

Case #4: Hemodynamic Support Decisions in Cardiogenic Shock

Presenter: Emmanouil S. Brilakis, Jose P.S. Henriques, Stefan K. James, Keith G. Oldroyd, Thomas D. Stuckey, William W. O'Neill

September 15, 2014

Presentation TCT 2014

Case #3: Identification of the Acute Culprit and Treatment of MVD in Cardiogenic Shock

Presenter: Emmanouil S. Brilakis, Jose P.S. Henriques, Stefan K. James, Keith G. Oldroyd, Thomas D. Stuckey, Holger Thiele

September 15, 2014

Presentation TCT 2014

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

Presenter: John A. Bittl, Tullio Palmerini, Joo Myung Lee, MD

September 15, 2014

Presentation TCT 2014

Case #2: Thrombus and an Open Infarct Artery: A Case for Deferred

Presenter: Emmanouil S. Brilakis, Jose P.S. Henriques, Stefan K. James, Keith G. Oldroyd, Thomas D. Stuckey, Henning Kelbæk

September 15, 2014

Presentation TCT 2014

Case #1: Targeting Massive Thrombus in Cardiogenic Shock

Presenter: Emmanouil S. Brilakis, Jose P.S. Henriques, Stefan K. James, Keith G. Oldroyd, Thomas D. Stuckey, Goran K. Olivecrona

September 15, 2014

News Conference News TCT 2014

Less Mortality with Paclitaxel-Coated Balloon vs. Stent in DES Restenosis

September 15, 2014

News Conference News TCT 2014

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

Yael L. Maxwell

September 14, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

Presentation TCT 2014

Basics of Interventional Pharmacology

Presenter: Manish A. Parikh, Robert T. Pyo, Jonathan Feig, Piera Capranzano

September 12, 2014

Presentation TCT 2014

DES Systems and Outcomes

Presenter: Manish A. Parikh, Robert T. Pyo, Jonathan Feig, Ziad A. Ali

September 12, 2014

Presentation TCT 2014

Atherotomy, Atherectomy, and Embolic Protection

Presenter: Manish A. Parikh, Robert T. Pyo, Jonathan Feig, Davide Capodanno

September 12, 2014

Presentation TCT 2014

Guiding Catheters, Wires, and Balloons: Equipment and Results

Presenter: Manish A. Parikh, Robert T. Pyo, Jonathan Feig

September 12, 2014

Presentation TCT 2014

Vascular Access Routes and Technique

Presenter: Manish A. Parikh, Robert T. Pyo, Jonathan Feig

September 12, 2014

Presentation TCT 2014

Cath Lab Room Setup

Presenter: Manish A. Parikh, Robert T. Pyo, Jonathan Feig

September 12, 2014

Presentation TCT 2013

Just Because You Want It to Be True Doesn't Mean It Is: None of These Technologies Have Been Proven to Be Superior to Balloon Angioplasty Only!

Presenter: Stefan James

October 31, 2013

News Conference News TCT 2013

Drug-coated Balloons May Become Standard of Care in ISR

October 31, 2013

Presentation TCT 2013

Motion: There is No Role for Thrombolysis in Modern STEMI Management - For: All Patients Should Receive Primary Angioplasty!

Presenter: Cindy Grines

October 30, 2013

Presentation TCT 2013

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

Presenter: Kenneth Rosenfield

October 30, 2013

Advertisement

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

Case #5: Resuscitated Out-of-Hospital Cardiac Arrest

Case #4: Hemodynamic Support Decisions in Cardiogenic Shock

Case #3: Identification of the Acute Culprit and Treatment of MVD in Cardiogenic Shock

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

Case #2: Thrombus and an Open Infarct Artery: A Case for Deferred

Case #1: Targeting Massive Thrombus in Cardiogenic Shock

Less Mortality with Paclitaxel-Coated Balloon vs. Stent in DES Restenosis

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

Basics of Interventional Pharmacology

DES Systems and Outcomes

Atherotomy, Atherectomy, and Embolic Protection

Guiding Catheters, Wires, and Balloons: Equipment and Results

Vascular Access Routes and Technique

Cath Lab Room Setup

Just Because You Want It to Be True Doesn't Mean It Is: None of These Technologies Have Been Proven to Be Superior to Balloon Angioplasty Only!

Drug-coated Balloons May Become Standard of Care in ISR

Motion: There is No Role for Thrombolysis in Modern STEMI Management - For: All Patients Should Receive Primary Angioplasty!

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content